According to a new report by Polaris Market Research, the global psoriasis drug market was valued at USD 22.63 billion in 2025 and is projected to reach USD 56.96 billion by 2034, expanding at a CAGR of 10.80% over the forecast period. Growth is underpinned by the rising global prevalence of psoriasis, advancing biologic and biosimilar therapies, and growing awareness of treatment...